Skip to content
- Ranloc. The most common symptoms of gastroesophageal reflux disease and heartburn and gastric acid reflux, dizziness, diarrhea, nausea, vomiting In order to alleviate these symptoms is recommended to use the medicinal product Ranloc Med 0.02 g, which contains the pantoprazole
Ranloc MED dizziness, diarrhea, nausea, vomiting Composition:
active substance - pantoprazole. An enteric-coated tablet contains 20 mg of pantoprazole (as sodium sesquihydrate) and the excipients: Tablet core: anhydrous sodium carbonate, mannitol, crospovidone type A, hydroxypropyl cellulose, microcrystalline cellulose, calcium stearate; Coating: Opadry Yellow 02H52369: hypromellose, propylene glycol, povidone K30, titanium dioxide (E 171), yellow iron oxide (E 172); Enteric coating: Methacrylic acid-ethyl acrylate copolymer (1: 1), triethyl citrate, sodium lauryl sulfate, titanium dioxide (E 171), talc, yellow iron oxide (E 172).
Ranloc MED dizziness, diarrhea, nausea, vomiting Function:
Used in the medicinal product Med Ranloc 0.02 g of active substance, ie pantoprazole is called. proton pump inhibitor. This means that the drug reduces the secretion of acid in the stomach. It can be used for short periods to treat symptoms such as heartburn and acid reflux. Although after the first dose, you can feel the relaxation of unpleasant symptoms, the drug should be taken to their full resignation, it usually takes 2-3 days.
Ranloc MED Application:
The medicinal product Ranloc Med 0.02g indicated for short-term use to treat the symptoms of gastroesophageal reflux disease (eg. Acid regurgitation, heartburn). The drug for adults.
Additional information:
Keep out of reach of children, at room temperature. The drug is not suitable for preventive use.
Contraindications
not be used in case of hypersensitivity to any component of the drug. Do not use concomitantly with atazanavir. Do not use below 18 years of age, and in women during pregnancy and lactation.
Adverse reactions:
While taking side effects may occur. Uncommon: headache, dizziness, diarrhea, nausea, vomiting, feeling of fullness in the abdomen and flatulence, constipation, dry mouth, pain and discomfort in the abdominal, skin rash or hives, itchy skin, weakness, exhaustion or general malaise, sleep disorders, elevated liver enzymes found in blood tests; rare: severe allergic reactions hypersensitivity (anaphylactic reactions, anaphylaxis and angioedema); disturbances in vision (blurred vision), arthralgia, myalgia, weight changes, pyrexia, edema, allergic reactions, depression, elevated indirect bilirubin, and lipids in the blood (detected in blood tests); very rare: disorientation; reduced platelet counts; reduction in the number of white blood cells; Not known: severe skin reactions: rash with swelling, blistering or skin peeling skin, lobar flaking skin and bleeding around eyes, nose, mouth or genitals and rapid deterioration of general condition or rash after sun exposure; yellow skin and eyes (due to severe liver damage), or kidney problems such as painful urination and pain in the lower back of fever; hallucinations, confusion (especially in patients whose symptoms occur before); reducing the concentration of sodium in the blood.
Dosage:
Use as directed by your doctor or according to the instructions on the leaflet. Taken orally. It is recommended to take one tablet once a day at a fixed time, should be taken before a meal. The tablet should be swallowed whole with a sufficient amount of water. Use 2-3 days until symptoms disappear. The maximum period of application of the drug without consulting your doctor 4 weeks. It is advisable to consult a doctor also in a situation where after two consecutive weeks of taking the drug, the symptoms do not go.